Explore more publications!

Reunion Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.

Press releases published on April 13, 2026

Four-Person Dutch Startup Launches Europe's First Sovereign AI Platform - Beyond the Reach of US Cloud Law
BGIN BLOCKCHAIN LIMITED Announces Resolution of Subsidiary’s Hosting Dispute and Full Recovery of Mining Machines
Springboards Launches ‘Flint’ to Break AI’s Habit of Predictable, Boring Answers
naoo AG lanciert METIS: Echtzeit-Experimentierinfrastruktur vervollständigt den proprietären KI-Stack
naoo AG Launches METIS: Real-Time Experimentation Infrastructure Completes Proprietary AI Stack
Smart Minimalism, Supreme Efficiency: CUKTECH 15 Charging Station Makes Its Debut in Malaysia
Berikut adalah terjemahan siaran akhbar tersebut ke dalam Bahasa Melayu: Minimalisme Pintar, Kecekapan Ulung: Stesen Pengecasan CUKTECH 15 Membuat Kemunculan Sulung di Malaysia
B2PRIME Group Awarded FX Solution Provider at WealthBriefing 2026
Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield
Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer
Over a third of Americans would accept twice as many ads for cheaper streaming
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
Zoonova AI Launches Alpha AI, Bringing Quant-Driven Analytics to Everyday Investors
A Grand Event for the Rubber and Plastics Industry — CYCJET Joins You at Chinaplas 2026
Un gran evento para la industria del caucho y el plástico: CYCJET lo invita a Chinaplas 2026
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene annonce la fin de la randomisation des patients de la partie Phase 2 de l’essai clinique évaluant TG4050 dans le traitement adjuvant des cancers de la tête et du cou
SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions